ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 113 filers reported holding ARGENX SE in Q4 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $540,000 | -55.6% | 1,712 | -68.3% | 0.00% | -50.0% |
| Q2 2020 | $1,216,000 | +7.1% | 5,400 | -37.3% | 0.00% | -33.3% |
| Q1 2020 | $1,135,000 | -89.1% | 8,616 | -86.7% | 0.00% | -87.5% |
| Q4 2019 | $10,412,000 | +1424.5% | 64,867 | +620.7% | 0.02% | +1100.0% |
| Q3 2018 | $683,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |